Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 281, Issue 1 50-1, 2001, Pages

  Hart, Chaki Y T ^a   Hahn, Eugenia L ^b   Meyer, Donna M ^a   Burnett Jr , John C ^a   Redfield, Margaret M ^a,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Division of Cardiovascular Diseases and Internal Medicine   (United States)

Author keywords

cGMP; Inotropy; Lusitropy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; HS 142 1; N(G) METHYLARGININE; NATRIURETIC FACTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEMODYNAMICS; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034803922     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.1.h146     Document Type: Article

References (52)

1. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
2. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
3. Nitric oxide attenuates cardiac myocyte contraction
4. Atrial natriuretic peptide elevation in congestive heart failure in the human
5. C-type natriuretic peptide: A selective cardiovascular peptide
6. Nitric oxide synthase activities in human myocardium
7. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
8. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
9. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve
10. Modulation of mouse cardiac function in vivo by eNOS and ANP
11. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
12. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of β-adrenergic inotropic responsiveness
13. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs
14. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction
15. Expression of inducible nitric oxide synthase in human heart failure
16. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange
17. β-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes
18. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure
19. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation
20. Molecular biology of the natriuretic peptides and their receptors
21. Effects of the natriuretic peptides on load and myocardial function in normal and heart failure dogs
22. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline
23. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
24. Gene expression of natriuretic peptide receptors in myocardial cells
25. Protein measurement with the folin phenol reagent
26. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
27. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle
28. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
29. Nitric oxide as a secretory product of mammalian cells
30. Natriuretic peptide receptor messenger RNAs in the rat and human heart
31. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure
32. Temporal alteration in endothelium-dependent responses of canine coronary arteries in congestive heart failure
33. Increased production of nitric oxide in coronary arteries during congestive heart failure
34. Vascular endothelial cells synthesize nitric oxide from L-arginine
35. CGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: Potential role for nitrosylation
36. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: Assessment of bicoronary sodium nitroprusside infusion
37. 8-Bromo-cGMP reduces the myofilament response to calcium in intact cardiac myocytes
38. Induction and potential biological relevance of a calcium-independent nitric oxide synthase in the myocardium
39. Redox signalling: Nitrosylation and related target interactions of nitric oxide
40. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides
41. Different effects of ANP and nitroprusside on cyclic GMP extrusion of isolated aorta
42. Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure
43. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes
44. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
45. Natriuretic peptide system in human heart failure
46. Hemodynamic determinants of the time course of fall in canine left ventricular pressure
47. Increased nitric oxide production in heart failure
48. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: Implications for the development of heart failure
49. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model
50. Effect of the endogenous natriuretic peptide system on ventricular and coronary function in the failing canine heart
51. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure